Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

YAO, JAMES C

One or more keywords matched the following items that are connected to YAO, JAMES C

Item Type	Name
Concept	Sirolimus
Academic Article	Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors.
Academic Article	mTOR inhibition, a potential novel approach for bronchial carcinoids.
Academic Article	The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy.
Academic Article	Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors.
Academic Article	Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study.
Academic Article	Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial.
Academic Article	New strategies for advanced neuroendocrine tumors in the era of targeted therapy.
Academic Article	PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors.
Academic Article	Everolimus in advanced pancreatic neuroendocrine tumors: the clinical experience.
Academic Article	Targeted therapies in neuroendocrine tumors (NET): clinical trial challenges and lessons learned.
Academic Article	Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer.
Academic Article	Perspectives in the development of novel treatment approaches.
Academic Article	Everolimus for advanced pancreatic neuroendocrine tumors.
Academic Article	Innovations therapy: mammalian target of rapamycin (mTOR) inhibitors for the treatment of neuroendocrine tumors.
Academic Article	Chromogranin A and neuron-specific enolase as prognostic markers in patients with advanced pNET treated with everolimus.
Academic Article	Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.
Academic Article	Glycemic control in patients with insulinoma treated with everolimus.
Academic Article	Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Na?ve Advanced Pancreatic Neuroendocrine Tumors.
Concept	Mechanistic Target of Rapamycin Complex 1
Concept	Mechanistic Target of Rapamycin Complex 2

Search Criteria

Sirolimus